Empagliflozin for No-reflow Phenomenon in PCI for STEMI

NCT06342141 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

162

Enrollment

OTHER

Sponsor class

Conditions

STEMI
No-Reflow Phenomenon

Interventions

DRUG: Empagliflozin 25 milgrams (Mg)
DRUG: Empagliflozin 10 Mg

Sponsor

Instituto Nacional de Cardiologia Ignacio Chavez